Skip to content

Biote Corp. BTMD Free cash flow

Free cash flow at other companies

Target logo
TargetTGT
-$319M+38.1%
Walmart
 logo
Walmart WMT
-$1.95B-558%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$3.58M
BioLife Solutions logo
BioLife SolutionsBLFS
-$658K-142%
Lifevantage Corporation logo
Lifevantage CorporationLFVN
$3.98M+110%
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
-$4.33M-389%

Other financials

Income statement

See full
Revenue$44.9M-8.3%
Gross profit$31.0M-14.9%
Operating income$3.2M-67.3%
Net income$2.3M-83.4%
EPS (diluted)$0.06-83.8%

Balance sheet

See full
Cash & equivalents$5.3M-87.2%
Total debt$103.4M-5.5%
Total equity-$56.1M+37.7%
Total assets$89.0M-27.8%

Cash flow

See full
Operating cash flow$3.9M-39.7%
CapEx$362.0K-77.8%

Valuation

See full
Market cap$57.33M-57.5%
Enterprise value$155.43M-30.3%
P/E3.7×-0.6×
P/S0.3×-0.4×

Profitability

See full
Gross margin70.1%-1.2pp
Operating margin15.4%-0.1pp
Net margin8.3%-2.3pp
FCF margin15.3%-3.2pp

Returns & leverage

See full
Return on equity-21.4%
Debt / equity9.1×
Current ratio1.3×-0.1×

Where this comes from

Calculated from Biote Corp.’s reported figures.

The official record: Biote Corp.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biote Corp.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biote Corp.'s free cash flow?
Biote Corp. (BTMD) reported free cash flow of $3.54M in Q1 2026.
How has Biote Corp.'s free cash flow changed year-over-year?
Biote Corp.'s free cash flow decreased by 26.8% year-over-year, from $4.84M to $3.54M.
What is the long-term trend for Biote Corp.'s free cash flow?
Over 2 years (2023 to 2025), Biote Corp.'s free cash flow has grown at a 6.1% compound annual growth rate (CAGR), from $26.82M to $30.18M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.